Y Intercept (Hong Kong) LTD Halozyme Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $105,317 - $131,177	3,127 Added 14.36%	24,900 $1.01 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $446,521 - $564,182	-13,401 Reduced 38.1%	21,773 $804,000
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $1.28 Million - $1.55 Million	35,174 New	35,174 $1.34 Million
Q1 2023 May 09, 2023	BUY	$32.86 - $55.7 $443,642 - $752,005	13,501 New	13,501 $515,000

488

122M

208K

66.3K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.93B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.